Integrating multiple omics information in the era of precision oncology

Inflammatory microenvironment regulates colorectal cancer progression

Innovations in assessing patient outcomes

Technologies for personalised cancer immunotherapies

Clinical cases employing novel agents in Hodgkin lymphoma

Cancer cells plasticity and drug resistance

Drugging “undruggable” transcription factor drivers in cancer

Combination therapy before surgery improves outcomes for patients with HER2 positive breast cancer

Elucidation and pharmacological targeting of tumour checkpoint dependencies

MINDACT breast cancer clinical trial: First results and impact on future trial design

Comparison of three different PD-L1 diagnostic tests shows a high degree of concordance

Imaging tumour habitats - life at the edge